Miller Anestesia

muscle from critically ill patients receiving muscle

relaxants: An investigation of the molecular mecha-

nism of prolonged paralysis. Crit Care Med 23:815–

821, 1995.

456. Coursin DB, Klasek G, Goelzer SL: Increased requi-

rements for continuously infused vecuronium in

critically ill patients. Anesth Analg 69:518–521,

1989.

457. Hughes M, Grant IS, Biccard B, Nimmo G: Suxame-

thonium and critical illness polyneuropathy.

Anaesth Intensive Care 27:636–638, 1999.

458. Kupfer Y, Namba T, Kaldawi E, Tessler S: Prolon-

ged weakness after long-term infusion of vecuro-

nium bromide. Ann Intern Med 117:484–486,

1992.

459. Op de Coul AA, Lambregts PC, Koeman J, et al:

Neuromuscular complications in patients given

Pavulon (pancuronium bromide) during artificial

ventilation. Clin Neurol Neurosurg 87:17–22,

1985.

460. Tousignant CP, Bevan DR, Eisen AA, et al: Acute

quadriparesis in an asthmatic treated with atracu-

rium. Can J Anaesth 42:224–227, 1995.

461. Gwinnutt CL, Eddleston JM, Edwards D, Pollard

BJ: Concentrations of atracurium and laudano-

sine in cerebrospinal fluid and plasma in three

intensive care patients. Br J Anaesth 65:829–832,

1990.

462. Szenohradszky J, Trevor AJ, Bickler P, et al: Central

nervous system effects of intrathecal muscle

relaxants in rats. Anesth Analg 76:1304–1309, 1993.

463. Griffiths RB,Hunter JM,Jones RS:Atracurium infu-

sions in patients with renal failure on an ITU.

Anaesthesia 41:375–381, 1986.

464. Beemer GH, Dawson PJ, Bjorksten AR, Edwards

NE: Early postoperative seizures in neurosurgical

patients administered atracurium and isoflurane.

Anaesth Intensive Care 17:504–509, 1989.

465. Eddleston JM, Harper NJ, Pollard BJ, et al: Concen-

trations of atracurium and laudanosine in cerebros-

pinal fluid and plasma during intracranial surgery.

Br J Anaesth 63:525–530, 1989.

466. Chiodini F, Charpantier E, Muller D, et al: Blockade

and activation of the human neuronal nicotinic

acetylcholine receptors by atracurium and laudano-

sine. Anesthesiology 94:643–651, 2001.

467. Prielipp RC, Coursin DB, Scuderi PE, et al: Compa-

rison of the infusion requirements and recovery

profiles of vecuronium and cisatracurium 51W89

in intensive care unit patients. Anesth Analg 81:3–

12, 1995.

468. Zarowitz BJ, Rudis MI, Lai K, et al: Retrospective

pharmacoeconomic evaluation of dosing vecuro-

nium by peripheral nerve stimulation versus stan-

dard clinical assessment in critically ill patients.

Pharmacotherapy 17:327–332, 1997.

469. Kress JP, Pohlman AS, O’Connor MF, Hall JB: Daily

interruption of sedative infusions in critically ill

patients undergoing mechanical ventilation. N Engl

J Med 342:1471–1477, 2000.

Farmacología de los relajantes musculares y sus antagonistas

677

Sección II

Farmacología y anestesia